9 Meters Biopharma

04/27/2023

In case you missed the recent news:
Links:
https://feeds.issuerdirect.com/news-release.html?newsid=8979124702089359
and
https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/jpen.2491

04/06/2023

On April 7, 2023, the World Health Organization (WHO) will mark its 75th anniversary, along with its 194 Member States and other partners, by calling for a renewed drive for health equity.” To learn more about the WHO please visit: https://www.who.int/campaigns/75-years-of-improving-public-health

03/28/2023

9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2022

03/14/2023

9 Meters Biopharma to present at the Oppenheimer 33rd Annual Healthcare Conference

Updated Presentation Date/Time:
Wednesday, March 15 at 10:00 AM ET

Gastrointestinal platform company focused on patients with rare disorders and unmet needs.

03/08/2023

9 Meters Biopharma to Present at the Oppenheimer 33rd Annual Healthcare Conference

John Temperato, President and Chief Executive Officer of 9 Meters, is scheduled to present.

Oppenheimer 33rd Annual Healthcare Conference

Date: Monday, March 13, 2023

Time: 3:20 PM ET

Webcast link:
https://wsw.com/webcast/oppenheimer27/register.aspx?conf=oppenheimer27&page=nmtr&url=https://wsw.com/webcast/oppenheimer27/nmtr/2821637

The presentation will highlight the Company's pipeline, with a focus on vurolenatide, its long-acting GLP-1 agonist in Phase 3 development for short bowel syndrome, as well as upcoming milestones.

The presentation will also be available in the events section of the 9 Meters website. A replay of the webcast will be available for 90 days after the date of the presentation.

03/01/2023

You're Not Alone.

If you or a family member are struggling with Short Bowel Syndrome here are some organizations that can help...

Oley Foundation: https://oley.org
United Ostomy Associations of America https://www.ostomy.org
ASPEN (American Society for Parenteral and Enteral Nutrition) https://lnkd.in/euudP7G2
National Organization for Rare Disorders https://rarediseases.org
Caregiver Action Network https://lnkd.in/gqsdizqQ
Intl. Foundation for Functional GI Disorders (IFFGD) https://iffgd.org

01/27/2023

Learn more about Short Bowel Syndrome.

Short bowel syndrome (SBS) is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine.

Check out the National Organization for Rare Disorders' (NORD) video library for an animated introduction of SBS: https://rarediseases.org/videos/short-bowel-syndrome/.

12/22/2022

Wishing everyone a happy and healthy holiday season! We’re looking forward to the new year ahead and continuing our mission to help patients with rare and debilitating digestive disorders.

12/20/2022

Our drug candidate for syndrome (SBS) is designed to counteract the low levels of the hormone GLP-1 seen in SBS. Restoring GLP-1 may slow gut motility to improve intestinal absorption of nutrients and water. Learn more: https://bit.ly/3aij8DW

12/15/2022

In case you missed it, we announced the design of our Phase 3 study evaluating our drug candidate for short bowel syndrome (SBS). Our team is looking forward to moving one step closer to potentially providing SBS patients with a new treatment option: https://bit.ly/3VCJcPJ

12/13/2022

We’re developing a potential microbiome modulator that was found to be effective alone or when combined with immune checkpoint inhibitors in a pre-clinical study for spontaneous aggressive skin melanoma. Learn more about our pipeline of candidates: https://bit.ly/3aij8DW

12/09/2022

Did you know the average length of the GI tract is about 9 meters? Within those 9 meters, the GI tract has multiple biologic functions that can be harnessed to fight disease. We’re putting the power of gut biology to work to address multiple digestive disease. Learn more: https://bit.ly/3a3gq4m